ZygosityPredictor
- PMID: 38560552
- PMCID: PMC10980564
- DOI: 10.1093/bioadv/vbae017
ZygosityPredictor
Abstract
Summary: ZygosityPredictor provides functionality to evaluate how many copies of a gene are affected by mutations in next generation sequencing data. In cancer samples, the tool processes both somatic and germline mutations. In particular, ZygosityPredictor computes the number of affected copies for single nucleotide variants and small insertions and deletions (Indels). In addition, the tool integrates information at gene level via phasing of several variants and subsequent logic to derive how strongly a gene is affected by mutations and provides a measure of confidence. This information is of particular interest in precision oncology, e.g. when assessing whether unmutated copies of tumor-suppressor genes remain.
Availability and implementation: ZygosityPredictor was implemented as an R-package and is available via Bioconductor at https://bioconductor.org/packages/ZygosityPredictor. Detailed documentation is provided in the vignette including application to an example genome.
© The Author(s) 2024. Published by Oxford University Press.
Conflict of interest statement
None declared.
Figures


References
-
- Campbell P, Getz G, Korbel J, et al.Pan-cancer analysis of whole genomes. Nature (London) 2020;578:129–36. - PubMed
-
- Horak P, Heining C, Kreutzfeldt S. et al. Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions in patients with rare cancers. Cancer Discov 2021;11:2780–95. - PubMed
-
- Hübschmann D, Schlesner M.. Evaluation of whole genome sequencing data. Methods Mol Biol 2019;1956:321–36. - PubMed
-
- Kleinheinz K, Bludau I, Hübschmann D. et al. ACEseq - Allele-specific Copy Number Estimation from Whole Genome Sequencing and its Application in Heterogeneity and Integrative Analyses of Cancer. BioRxiv, Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory, 2017.
LinkOut - more resources
Full Text Sources